Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia- United States

doi 10.1016/j.clml.2014.07.011

Full Text

Abstract

Available in

Categories

Cancer Research

Date

February 1, 2015

Authors

Alfonso Quintás-Cardama

Nianxiang Zhang

Chad J. Creighton

Kevin R. Coombes

Steven M. Kornblau

Publisher

Elsevier BV

Related search

HES1 Is an Independent Prognostic Factor for Acute Myeloid Leukemia

OncoTargets and Therapy

English

Prognostic Impact of MYH9 Expression on Patients With Acute Myeloid Leukemia

English

Human BDH2, an Anti-Apoptosis Factor, Is a Novel Poor Prognostic Factor for De Novo Cytogenetically Normal Acute Myeloid Leukemia

Journal of Biomedical Science

Clinical Biochemistry

Molecular Biology

English

Lymphatic Invasion Is an Independent Adverse Prognostic Factor in Patients With Colorectal Liver Metastasis

Annals of Surgical Oncology

English

Frequent Loss of RAF Kinase Inhibitor Protein Expression in Acute Myeloid Leukemia

Cancer Research

English

SALL1 Expression in Acute Myeloid Leukemia

English

Prognostic Significance of Hyperdiploidy in Adult Acute Myeloid Leukemia

American Journal of Hematology

English

Overexpression of ATP1B1 Predicts an Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia

English

Met Expression Is an Independent Prognostic Risk Factor in Patients With Oesophageal Adenocarcinoma

British Journal of Cancer

Cancer Research

English